236 related articles for article (PubMed ID: 9164954)
1. Involvement of NK1+ CD4- CD8- alphabeta T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice.
Nakamura E; Kubota H; Sato M; Sugie T; Yoshida O; Minato N
J Immunol; 1997 Jun; 158(11):5338-48. PubMed ID: 9164954
[TBL] [Abstract][Full Text] [Related]
2. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
[TBL] [Abstract][Full Text] [Related]
3. Development of CD4-CD8- alpha beta TCR+NK1.1+ T lymphocytes: thymic selection by self antigen.
Schulz RJ; Parkes A; Mizoguchi E; Bhan AK; Koyasu S
J Immunol; 1996 Nov; 157(10):4379-89. PubMed ID: 8906813
[TBL] [Abstract][Full Text] [Related]
4. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population.
von der Weid T; Beebe AM; Roopenian DC; Coffman RL
J Immunol; 1996 Nov; 157(10):4421-7. PubMed ID: 8906817
[TBL] [Abstract][Full Text] [Related]
5. IL-7 up-regulates IL-4 production by splenic NK1.1+ and NK1.1- MHC class I-like/CD1-dependent CD4+ T cells.
Hameg A; Gouarin C; Gombert JM; Hong S; Van Kaer L; Bach JF; Herbelin A
J Immunol; 1999 Jun; 162(12):7067-74. PubMed ID: 10358149
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of Ly49 expression on CD4+ and CD4-CD8- (double negative) NK1.1+ T cells.
Sköld M; Cardell S
Eur J Immunol; 2000 Sep; 30(9):2488-96. PubMed ID: 11009081
[TBL] [Abstract][Full Text] [Related]
7. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
[TBL] [Abstract][Full Text] [Related]
8. Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis.
Takeda K; Seki S; Ogasawara K; Anzai R; Hashimoto W; Sugiura K; Takahashi M; Satoh M; Kumagai K
J Immunol; 1996 May; 156(9):3366-73. PubMed ID: 8617962
[TBL] [Abstract][Full Text] [Related]
9. Developmental and functional analyses of CD8(+) NK1.1(+) T cells in class-I-restricted TCR transgenic mice.
Ohwatari R; Iwabuchi K; Iwabuchi C; Morohashi T; Sawa H; Hioki K; Kobayashi K; Fukuda S; Inuyama Y; Onoé K
Cell Immunol; 2001 Oct; 213(1):24-33. PubMed ID: 11747353
[TBL] [Abstract][Full Text] [Related]
10. Splenic NK1.1-negative, TCR alpha beta intermediate CD4+ T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation.
Moodycliffe AM; Maiti S; Ullrich SE
J Immunol; 1999 May; 162(9):5156-63. PubMed ID: 10227987
[TBL] [Abstract][Full Text] [Related]
11. CD3+4-8- alpha beta T cell population with biased T cell receptor V gene usage. Presence in bone marrow and possible involvement of IL-3 for their extrathymic development.
Kubota H; Okazaki H; Onuma M; Kano S; Hattori M; Minato N
J Immunol; 1992 Aug; 149(4):1143-50. PubMed ID: 1323608
[TBL] [Abstract][Full Text] [Related]
12. Lymphokine-activated killer cells. VII. IL-4 induces an NK1.1+CD8 alpha+beta- TCR-alpha beta B220+ lymphokine-activated killer subset.
Ballas ZK; Rasmussen W
J Immunol; 1993 Jan; 150(1):17-30. PubMed ID: 7678028
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12.
Hashimoto W; Takeda K; Anzai R; Ogasawara K; Sakihara H; Sugiura K; Seki S; Kumagai K
J Immunol; 1995 May; 154(9):4333-40. PubMed ID: 7722291
[TBL] [Abstract][Full Text] [Related]
14. Age-associated rapid and Stat6-independent IL-4 production by NK1-CD4+8- thymus T lymphocytes.
Chen YT; Chen FL; Kung JT
J Immunol; 1999 Nov; 163(9):4747-53. PubMed ID: 10528173
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice.
Kawamura T; Seki S; Takeda K; Narita J; Ebe Y; Naito M; Hiraide H; Abo T
Cell Immunol; 1999 May; 193(2):219-25. PubMed ID: 10222065
[TBL] [Abstract][Full Text] [Related]
16. Natural killer-like T cells develop in SJL mice despite genetically distinct defects in NK1.1 expression and in inducible interleukin-4 production.
Beutner U; Launois P; Ohteki T; Louis JA; MacDonald HR
Eur J Immunol; 1997 Apr; 27(4):928-34. PubMed ID: 9130646
[TBL] [Abstract][Full Text] [Related]
17. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T
J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653
[TBL] [Abstract][Full Text] [Related]
18. Regulatory role of peritoneal NK1.1+ alpha beta T cells in IL-12 production during Salmonella infection.
Naiki Y; Nishimura H; Kawano T; Tanaka Y; Itohara S; Taniguchi M; Yoshikai Y
J Immunol; 1999 Aug; 163(4):2057-63. PubMed ID: 10438944
[TBL] [Abstract][Full Text] [Related]
19. Role for IL-15/IL-15 receptor beta-chain in natural killer 1.1+ T cell receptor-alpha beta+ cell development.
Ohteki T; Ho S; Suzuki H; Mak TW; Ohashi PS
J Immunol; 1997 Dec; 159(12):5931-5. PubMed ID: 9550390
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus.
Zeng D; Gazit G; Dejbakhsh-Jones S; Balk SP; Snapper S; Taniguchi M; Strober S
J Immunol; 1999 Nov; 163(10):5338-45. PubMed ID: 10553057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
